禮來

935.57
Open
945.00
Market Cap
883.95B+
High
957.69
Low
930.02
Close
935.58
Volume
2.73M+
P/E Ratio
40.77
Div/Yield
0.64%

About 禮來

Eli Lilly and Company 在全球發現、開發和銷售人類藥物。它提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、賴脯胰島素、賴脯胰島素魚精蛋白、賴脯胰島素混合物 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用於糖尿病; 2 型糖尿病的 Jardiance、Trajenta 和 Trulicity。公司為非小細胞肺癌(NSCLC)和惡性胸膜間皮瘤提供Alimta; Cyramza 用於轉移性胃癌、胃食管交界處腺癌、轉移性非小細胞肺癌、轉移性結直腸癌和肝細胞癌; Erbitux 用於結直腸癌和各種頭頸癌; Retevmo 用於轉移性非小細胞肺癌、甲狀腺髓樣癌和甲狀腺癌; Tyvyt 用於復發性或難治性經典霍奇金淋巴和非鱗狀非小細胞肺癌;和 Verzenio 用於 HR+、HER2- 轉移性乳腺癌、淋巴結陽性和早期乳腺癌。它為類風濕性關節炎提供 Olumiant; Taltz 用於治療斑塊狀銀屑病、銀屑病關節炎、強直性脊柱炎和非放射學中軸性脊柱炎。該公司為抑鬱症、糖尿病周圍神經性疼痛、廣泛性焦慮症、纖維肌痛和慢性肌肉骨骼疼痛提供 Cymbalta; Emgality 用於預防偏頭痛和發作性叢集性頭痛; Zyprexa 用於精神分裂症、雙相 I 型障礙和雙相維持。它的 Bamlanivimab 和 etesevimab,以及用於 COVID-19 的 Bebtelovimab; Cialis 用於勃起功能障礙和良性前列腺增生;和 Forteo 用於治療骨質疏鬆症。公司與 Incyte Corporation 有合作;勃林格殷格翰製藥公司; AbCelera 生物製品公司;君實生物; Regor 治療集團; Lycia Therapeutics , Inc .;金桔生物科學公司;恩托斯製藥公司;和 Foghorn Therapeutics Inc. Eli Lilly and Company 成立於 1876 年,總部位於印第安納州印第安納波利斯。

如何購買 禮來 (LLY)

登入
1分鐘開戶

1分鐘開戶

僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助,支援 RockFlow App 和網頁端操作。

充值資金

充值資金

帳戶驗證完成後,您可以使用首選的支付方式向帳戶充值。

購買 LLY

購買 LLY

透過 RockFlow App 或網頁端搜尋 LLY,輸入您想要投資的金額,然後點擊確認即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.